GL1X · GenesisL1 explorer

Research workbench

Structure of PIK3CA with covalent inhibitor 19

Analyse Structure of PIK3CA with covalent inhibitor 19 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7R9V
Type
protein
Length
855 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P42336
Ligands
2Q7
Pockets
11 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153, 2.7.11.1)protein85545% helix, 18% strandP42336

Ligands and binding sites

  • 2Q7 · N-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111960.840.8483empty
210580.770.79105empty
3990.750.9625empty
42330.630.81292Q7
51950.520.7725empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7R9V · Structure of PIK3CA with covalent inhibitor 19 · the same entry in another collection · chain A against A, TM-score 1.00
  • P42336 · AlphaFold monomer V2.0 prediction for phosphatidylinositol 4,5-bisphosphate 3-kinase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.